Errors involving pediatric patients receiving chemotherapy: a literature review

Medical and Pediatric Oncology
R Trinkle, J K Wu

Abstract

A review of mishaps involving pediatric patients receiving anticancer chemotherapy was undertaken in order to assist intervention. Although the case literature is too sparse to provide definite recommendations, suggestions for management are made in the event of an error with a high risk (based on the case literature) of life-threatening toxicities. It is recommended that all incidents be reported in the literature in order to provide a basis for devising standard treatment protocols. It is also suggested that studies using animal models continue to be done in order to provide more experimental data about toxicities and potentially beneficial rescue therapies.

References

Jun 1, 1975·Australian and New Zealand Journal of Medicine·C J Wakem, J M Bennett
Oct 1, 1976·The Journal of Pediatrics·I A KaufmanS T Giammona
Jan 1, 1978·Medical and Pediatric Oncology·D A ShepherdD J Fernbach
Jan 1, 1979·Clinical Toxicology·O C Grush, S K Morgan
Jun 1, 1977·The Journal of Pediatrics·M Casteels-Vann DaeleP Baines
Jan 1, 1992·Annals of Tropical Paediatrics·I M al Fawaz
Jul 18, 1992·Lancet·J Y PiergaP Pouillart
Jan 1, 1992·Medical and Pediatric Oncology·M E MortensenR Batley
Apr 1, 1991·Pediatric Hematology and Oncology·H V KosmidisA Kostakis
Apr 1, 1990·Drugs·D J Black, R B Livingston
Apr 1, 1990·The Journal of Clinical Endocrinology and Metabolism·E S OrwollT Mann
Jan 1, 1990·Medical and Pediatric Oncology·M AricóG R Burgio
Nov 1, 1988·The Journal of Emergency Medicine·S A VandenbergB H Rumack
Jan 1, 1987·Pediatric Hematology and Oncology·R Wegelius
May 1, 1988·Medical Toxicology and Adverse Drug Experience·P LafolieC Peterson
Jan 1, 1988·Cancer Chemotherapy and Pharmacology·I A ChoonaraC C Bailey
Nov 1, 1974·The Journal of Pediatrics·A W PruittJ H Patterson
Aug 1, 1968·American Journal of Diseases of Children·A A Green, J L Naiman
Oct 1, 1968·Journal of Neuropathology and Experimental Neurology·S S SchochetK M Earle
Nov 3, 1984·Lancet·T D Coates
Jan 1, 1982·Journal of Neurology·J ManelisJ Doron
Aug 9, 1984·The New England Journal of Medicine·R J SpiegelJ Mangiardi
Feb 1, 1981·Annals of Neurology·T N ByrneM A Finer
Jul 16, 1981·The New England Journal of Medicine·R C YoungC E Myers
Jan 1, 1993·Pediatric Hematology and Oncology·S Hachimi-IdrissiJ Otten
Sep 21, 1957·Journal of the American Medical Association·S WOLFSON, M B OLNEY

❮ Previous
Next ❯

Citations

Apr 12, 2000·British Journal of Haematology·C V Fernandez
Feb 14, 2002·British Journal of Haematology·Jonathan AllardSuzette Woodward
Aug 13, 2013·Expert Opinion on Drug Safety·Jolanda M MaaskantHester Vermeulen
Sep 7, 2002·Journal of Toxicology. Clinical Toxicology·Andrés AlcarazAlberto Medina
Sep 22, 2005·British Journal of Haematology·Merete Stubkjaer ChristensenUNKNOWN Nordic Society of Paediatric Haematology and Oncology (NOPHO)
May 4, 2010·Journal of Chemotherapy·M ScalzoneR Riccardi
Sep 13, 2003·The Journal of Pediatrics·Conrad V Fernandez, Jane Gillis-Ring
Oct 20, 2004·Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses·Daniel J FranceJames A Whitlock
Dec 3, 2004·Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses·Connie DinningAmy Billett
Apr 23, 2013·The Annals of Pharmacotherapy·Rachel ThienprayoonDaniel C Bowers
Feb 28, 2004·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Michael A CiminoUNKNOWN Child Health Accountability Initiative
Apr 30, 2002·Medical and Pediatric Oncology·Bernhard ErdlenbruchLise M Bjerre
Apr 29, 1999·Medical and Pediatric Oncology·R A AndersonM J Coppes
Jul 1, 1997·Medical and Pediatric Oncology·H van den BergJ Bras
May 8, 2008·Current Neurology and Neuroscience Reports·Kevin C De Braganca, Roger J Packer
Oct 26, 2005·Cancer·Tejal K GandhiDavid W Bates
May 17, 2001·Paediatric Drugs·A RuggieroR Riccardi
May 1, 1997·Journal of Pediatric Hematology/oncology·R Trinkle, J K Wu
May 25, 2010·Journal of Pediatric Hematology/oncology·Ahmed Naqvi, Zehra Fadoo
Jan 22, 1998·Medical and Pediatric Oncology·D K Stones
Dec 17, 2004·Pediatric Blood & Cancer·Monica SpillerGianni Bisogno
May 4, 2005·The American Journal of Nursing·Ronda G Hughes, Elizabeth A Edgerton
Dec 28, 1999·Medical and Pediatric Oncology·T RévészC Rademaker
Feb 15, 2001·Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses·T D SieversP J Blanding
Aug 1, 1997·Medical and Pediatric Oncology·A W Walter
Nov 25, 2004·Journal of Surgical Oncology·Janice E Sullivan, John J Buchino
Apr 18, 2003·Joint Commission Journal on Quality and Safety·Daniel J FranceJames A Whitlock
Sep 5, 2003·Joint Commission Journal on Quality and Safety·Benjamin C GrassoDavid W Bates

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.